Research
Association between GLP-1 receptor agonist use and risk of repeat colonoscopy: a real-world cohort study with exploratory discontinuation analyses
Nature ·
The Brief
- A real-world cohort study examined whether GLP-1 receptor agonist use is associated with risk of repeat colonoscopy.
- The paper also includes exploratory analyses of discontinuation of GLP-1 receptor agonists.
- The source feed provided only the title and link, with no summary available.
Why it matters
Repeat colonoscopy is a common, costly part of colorectal screening and surveillance, so findings on whether GLP-1 receptor agonist use is linked to it may matter for clinicians and patients using these drugs.
Who’s affected
- clinicians and gastroenterologists
- patients using GLP-1 receptor agonists
- researchers in colorectal screening and pharmacoepidemiology
- #glp-1
- #colonoscopy
- #colorectal screening
- #real-world evidence
- #cohort study